0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Amoxicillin Antibiotic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-9U12443
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Amoxicillin Antibiotic Market Research Report 2022
BUY CHAPTERS

Amoxicillin Antibiotic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-9U12443
Report
December 2024
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Amoxicillin Antibiotic - Market Size

The global market for Amoxicillin Antibiotic was estimated to be worth US$ 4613 million in 2023 and is forecast to a readjusted size of US$ 5851.7 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Amoxicillin Antibiotic - Market

Amoxicillin Antibiotic - Market

Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amoxicillin Antibiotic, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Amoxicillin Antibiotic by region & country, by Type, and by Application.
The Amoxicillin Antibiotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amoxicillin Antibiotic.
Market Segmentation

Scope of Amoxicillin Antibiotic - Market Report

Report Metric Details
Report Name Amoxicillin Antibiotic - Market
Forecasted market size in 2030 US$ 5851.7 million
CAGR 3.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Pill
  • Capsule
  • Powder
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company United Laboratories, Sun Pharma, CSPC, LKPC, Hikma Pharmaceuticals USA Inc., Dr. Reddy, HPGC, Aurobindo Pharma, Meiji Holdings, GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Amoxicillin Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Amoxicillin Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Amoxicillin Antibiotic in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Amoxicillin Antibiotic - Market size in 2030?

Ans: The Amoxicillin Antibiotic - Market size in 2030 will be US$ 5851.7 million.

What is the Amoxicillin Antibiotic - Market share by region?

Ans: Europe is the largest market, with a share over 29%.

Who are the main players in the Amoxicillin Antibiotic - Market report?

Ans: The main players in the Amoxicillin Antibiotic - Market are United Laboratories, Sun Pharma, CSPC, LKPC, Hikma Pharmaceuticals USA Inc., Dr. Reddy, HPGC, Aurobindo Pharma, Meiji Holdings, GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC

What are the Application segmentation covered in the Amoxicillin Antibiotic - Market report?

Ans: The Applications covered in the Amoxicillin Antibiotic - Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Amoxicillin Antibiotic - Market report?

Ans: The Types covered in the Amoxicillin Antibiotic - Market report are Pill, Capsule, Powder

1 Market Overview
1.1 Amoxicillin Antibiotic Product Introduction
1.2 Global Amoxicillin Antibiotic Market Size Forecast
1.2.1 Global Amoxicillin Antibiotic Sales Value (2019-2030)
1.2.2 Global Amoxicillin Antibiotic Sales Volume (2019-2030)
1.2.3 Global Amoxicillin Antibiotic Sales Price (2019-2030)
1.3 Amoxicillin Antibiotic Market Trends & Drivers
1.3.1 Amoxicillin Antibiotic Industry Trends
1.3.2 Amoxicillin Antibiotic Market Drivers & Opportunity
1.3.3 Amoxicillin Antibiotic Market Challenges
1.3.4 Amoxicillin Antibiotic Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Amoxicillin Antibiotic Players Revenue Ranking (2023)
2.2 Global Amoxicillin Antibiotic Revenue by Company (2019-2024)
2.3 Global Amoxicillin Antibiotic Players Sales Volume Ranking (2023)
2.4 Global Amoxicillin Antibiotic Sales Volume by Company Players (2019-2024)
2.5 Global Amoxicillin Antibiotic Average Price by Company (2019-2024)
2.6 Key Manufacturers Amoxicillin Antibiotic Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Amoxicillin Antibiotic Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Amoxicillin Antibiotic
2.9 Amoxicillin Antibiotic Market Competitive Analysis
2.9.1 Amoxicillin Antibiotic Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Amoxicillin Antibiotic Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amoxicillin Antibiotic as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pill
3.1.2 Capsule
3.1.3 Powder
3.2 Global Amoxicillin Antibiotic Sales Value by Type
3.2.1 Global Amoxicillin Antibiotic Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Amoxicillin Antibiotic Sales Value, by Type (2019-2030)
3.2.3 Global Amoxicillin Antibiotic Sales Value, by Type (%) (2019-2030)
3.3 Global Amoxicillin Antibiotic Sales Volume by Type
3.3.1 Global Amoxicillin Antibiotic Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Amoxicillin Antibiotic Sales Volume, by Type (2019-2030)
3.3.3 Global Amoxicillin Antibiotic Sales Volume, by Type (%) (2019-2030)
3.4 Global Amoxicillin Antibiotic Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Amoxicillin Antibiotic Sales Value by Application
4.2.1 Global Amoxicillin Antibiotic Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Amoxicillin Antibiotic Sales Value, by Application (2019-2030)
4.2.3 Global Amoxicillin Antibiotic Sales Value, by Application (%) (2019-2030)
4.3 Global Amoxicillin Antibiotic Sales Volume by Application
4.3.1 Global Amoxicillin Antibiotic Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Amoxicillin Antibiotic Sales Volume, by Application (2019-2030)
4.3.3 Global Amoxicillin Antibiotic Sales Volume, by Application (%) (2019-2030)
4.4 Global Amoxicillin Antibiotic Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Amoxicillin Antibiotic Sales Value by Region
5.1.1 Global Amoxicillin Antibiotic Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Amoxicillin Antibiotic Sales Value by Region (2019-2024)
5.1.3 Global Amoxicillin Antibiotic Sales Value by Region (2025-2030)
5.1.4 Global Amoxicillin Antibiotic Sales Value by Region (%), (2019-2030)
5.2 Global Amoxicillin Antibiotic Sales Volume by Region
5.2.1 Global Amoxicillin Antibiotic Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Amoxicillin Antibiotic Sales Volume by Region (2019-2024)
5.2.3 Global Amoxicillin Antibiotic Sales Volume by Region (2025-2030)
5.2.4 Global Amoxicillin Antibiotic Sales Volume by Region (%), (2019-2030)
5.3 Global Amoxicillin Antibiotic Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Amoxicillin Antibiotic Sales Value, 2019-2030
5.4.2 North America Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Amoxicillin Antibiotic Sales Value, 2019-2030
5.5.2 Europe Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Amoxicillin Antibiotic Sales Value, 2019-2030
5.6.2 Asia Pacific Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Amoxicillin Antibiotic Sales Value, 2019-2030
5.7.2 South America Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Amoxicillin Antibiotic Sales Value, 2019-2030
5.8.2 Middle East & Africa Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Amoxicillin Antibiotic Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Amoxicillin Antibiotic Sales Value
6.2.1 Key Countries/Regions Amoxicillin Antibiotic Sales Value, 2019-2030
6.2.2 Key Countries/Regions Amoxicillin Antibiotic Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Amoxicillin Antibiotic Sales Value, 2019-2030
6.3.2 United States Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Amoxicillin Antibiotic Sales Value, 2019-2030
6.4.2 Europe Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Amoxicillin Antibiotic Sales Value, 2019-2030
6.5.2 China Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.5.3 China Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Amoxicillin Antibiotic Sales Value, 2019-2030
6.6.2 Japan Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Amoxicillin Antibiotic Sales Value, 2019-2030
6.7.2 South Korea Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Amoxicillin Antibiotic Sales Value, 2019-2030
6.8.2 Southeast Asia Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Amoxicillin Antibiotic Sales Value, 2019-2030
6.9.2 India Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
6.9.3 India Amoxicillin Antibiotic Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 United Laboratories
7.1.1 United Laboratories Company Information
7.1.2 United Laboratories Introduction and Business Overview
7.1.3 United Laboratories Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.1.4 United Laboratories Amoxicillin Antibiotic Product Offerings
7.1.5 United Laboratories Recent Development
7.2 Sun Pharma
7.2.1 Sun Pharma Company Information
7.2.2 Sun Pharma Introduction and Business Overview
7.2.3 Sun Pharma Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sun Pharma Amoxicillin Antibiotic Product Offerings
7.2.5 Sun Pharma Recent Development
7.3 CSPC
7.3.1 CSPC Company Information
7.3.2 CSPC Introduction and Business Overview
7.3.3 CSPC Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CSPC Amoxicillin Antibiotic Product Offerings
7.3.5 CSPC Recent Development
7.4 LKPC
7.4.1 LKPC Company Information
7.4.2 LKPC Introduction and Business Overview
7.4.3 LKPC Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.4.4 LKPC Amoxicillin Antibiotic Product Offerings
7.4.5 LKPC Recent Development
7.5 Hikma Pharmaceuticals USA Inc.
7.5.1 Hikma Pharmaceuticals USA Inc. Company Information
7.5.2 Hikma Pharmaceuticals USA Inc. Introduction and Business Overview
7.5.3 Hikma Pharmaceuticals USA Inc. Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hikma Pharmaceuticals USA Inc. Amoxicillin Antibiotic Product Offerings
7.5.5 Hikma Pharmaceuticals USA Inc. Recent Development
7.6 Dr. Reddy
7.6.1 Dr. Reddy Company Information
7.6.2 Dr. Reddy Introduction and Business Overview
7.6.3 Dr. Reddy Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Dr. Reddy Amoxicillin Antibiotic Product Offerings
7.6.5 Dr. Reddy Recent Development
7.7 HPGC
7.7.1 HPGC Company Information
7.7.2 HPGC Introduction and Business Overview
7.7.3 HPGC Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.7.4 HPGC Amoxicillin Antibiotic Product Offerings
7.7.5 HPGC Recent Development
7.8 Aurobindo Pharma
7.8.1 Aurobindo Pharma Company Information
7.8.2 Aurobindo Pharma Introduction and Business Overview
7.8.3 Aurobindo Pharma Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Aurobindo Pharma Amoxicillin Antibiotic Product Offerings
7.8.5 Aurobindo Pharma Recent Development
7.9 Meiji Holdings
7.9.1 Meiji Holdings Company Information
7.9.2 Meiji Holdings Introduction and Business Overview
7.9.3 Meiji Holdings Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Meiji Holdings Amoxicillin Antibiotic Product Offerings
7.9.5 Meiji Holdings Recent Development
7.10 GSK
7.10.1 GSK Company Information
7.10.2 GSK Introduction and Business Overview
7.10.3 GSK Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.10.4 GSK Amoxicillin Antibiotic Product Offerings
7.10.5 GSK Recent Development
7.11 Novartis
7.11.1 Novartis Company Information
7.11.2 Novartis Introduction and Business Overview
7.11.3 Novartis Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Novartis Amoxicillin Antibiotic Product Offerings
7.11.5 Novartis Recent Development
7.12 Centrient Pharma
7.12.1 Centrient Pharma Company Information
7.12.2 Centrient Pharma Introduction and Business Overview
7.12.3 Centrient Pharma Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Centrient Pharma Amoxicillin Antibiotic Product Offerings
7.12.5 Centrient Pharma Recent Development
7.13 Teva
7.13.1 Teva Company Information
7.13.2 Teva Introduction and Business Overview
7.13.3 Teva Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Teva Amoxicillin Antibiotic Product Offerings
7.13.5 Teva Recent Development
7.14 Mylan
7.14.1 Mylan Company Information
7.14.2 Mylan Introduction and Business Overview
7.14.3 Mylan Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Mylan Amoxicillin Antibiotic Product Offerings
7.14.5 Mylan Recent Development
7.15 Cipla
7.15.1 Cipla Company Information
7.15.2 Cipla Introduction and Business Overview
7.15.3 Cipla Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Cipla Amoxicillin Antibiotic Product Offerings
7.15.5 Cipla Recent Development
7.16 NCPC
7.16.1 NCPC Company Information
7.16.2 NCPC Introduction and Business Overview
7.16.3 NCPC Amoxicillin Antibiotic Sales, Revenue and Gross Margin (2019-2024)
7.16.4 NCPC Amoxicillin Antibiotic Product Offerings
7.16.5 NCPC Recent Development
8 Industry Chain Analysis
8.1 Amoxicillin Antibiotic Industrial Chain
8.2 Amoxicillin Antibiotic Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Amoxicillin Antibiotic Sales Model
8.5.2 Sales Channel
8.5.3 Amoxicillin Antibiotic Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Amoxicillin Antibiotic Market Trends
    Table 2. Amoxicillin Antibiotic Market Drivers & Opportunity
    Table 3. Amoxicillin Antibiotic Market Challenges
    Table 4. Amoxicillin Antibiotic Market Restraints
    Table 5. Global Amoxicillin Antibiotic Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Amoxicillin Antibiotic Revenue Market Share by Company (2019-2024)
    Table 7. Global Amoxicillin Antibiotic Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Amoxicillin Antibiotic Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Amoxicillin Antibiotic Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Amoxicillin Antibiotic Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Amoxicillin Antibiotic Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Amoxicillin Antibiotic
    Table 13. Global Amoxicillin Antibiotic Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amoxicillin Antibiotic as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Amoxicillin Antibiotic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Amoxicillin Antibiotic Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Amoxicillin Antibiotic Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Amoxicillin Antibiotic Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Amoxicillin Antibiotic Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Amoxicillin Antibiotic Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Amoxicillin Antibiotic Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Amoxicillin Antibiotic Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Amoxicillin Antibiotic Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Amoxicillin Antibiotic Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Amoxicillin Antibiotic Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Amoxicillin Antibiotic Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Amoxicillin Antibiotic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Amoxicillin Antibiotic Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Amoxicillin Antibiotic Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Amoxicillin Antibiotic Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Amoxicillin Antibiotic Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Amoxicillin Antibiotic Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Amoxicillin Antibiotic Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Amoxicillin Antibiotic Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Amoxicillin Antibiotic Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Amoxicillin Antibiotic Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Amoxicillin Antibiotic Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Amoxicillin Antibiotic Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Amoxicillin Antibiotic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Amoxicillin Antibiotic Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Amoxicillin Antibiotic Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Amoxicillin Antibiotic Sales Value by Region (2019-2024) & (%)
    Table 44. Global Amoxicillin Antibiotic Sales Value by Region (2025-2030) & (%)
    Table 45. Global Amoxicillin Antibiotic Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Amoxicillin Antibiotic Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Amoxicillin Antibiotic Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Amoxicillin Antibiotic Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Amoxicillin Antibiotic Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Amoxicillin Antibiotic Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Amoxicillin Antibiotic Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Amoxicillin Antibiotic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Amoxicillin Antibiotic Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Amoxicillin Antibiotic Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Amoxicillin Antibiotic Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Amoxicillin Antibiotic Sales Volume, (2025-2030) & (K Units)
    Table 57. United Laboratories Company Information
    Table 58. United Laboratories Introduction and Business Overview
    Table 59. United Laboratories Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. United Laboratories Amoxicillin Antibiotic Product Offerings
    Table 61. United Laboratories Recent Development
    Table 62. Sun Pharma Company Information
    Table 63. Sun Pharma Introduction and Business Overview
    Table 64. Sun Pharma Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sun Pharma Amoxicillin Antibiotic Product Offerings
    Table 66. Sun Pharma Recent Development
    Table 67. CSPC Company Information
    Table 68. CSPC Introduction and Business Overview
    Table 69. CSPC Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. CSPC Amoxicillin Antibiotic Product Offerings
    Table 71. CSPC Recent Development
    Table 72. LKPC Company Information
    Table 73. LKPC Introduction and Business Overview
    Table 74. LKPC Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. LKPC Amoxicillin Antibiotic Product Offerings
    Table 76. LKPC Recent Development
    Table 77. Hikma Pharmaceuticals USA Inc. Company Information
    Table 78. Hikma Pharmaceuticals USA Inc. Introduction and Business Overview
    Table 79. Hikma Pharmaceuticals USA Inc. Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Hikma Pharmaceuticals USA Inc. Amoxicillin Antibiotic Product Offerings
    Table 81. Hikma Pharmaceuticals USA Inc. Recent Development
    Table 82. Dr. Reddy Company Information
    Table 83. Dr. Reddy Introduction and Business Overview
    Table 84. Dr. Reddy Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Dr. Reddy Amoxicillin Antibiotic Product Offerings
    Table 86. Dr. Reddy Recent Development
    Table 87. HPGC Company Information
    Table 88. HPGC Introduction and Business Overview
    Table 89. HPGC Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. HPGC Amoxicillin Antibiotic Product Offerings
    Table 91. HPGC Recent Development
    Table 92. Aurobindo Pharma Company Information
    Table 93. Aurobindo Pharma Introduction and Business Overview
    Table 94. Aurobindo Pharma Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Aurobindo Pharma Amoxicillin Antibiotic Product Offerings
    Table 96. Aurobindo Pharma Recent Development
    Table 97. Meiji Holdings Company Information
    Table 98. Meiji Holdings Introduction and Business Overview
    Table 99. Meiji Holdings Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Meiji Holdings Amoxicillin Antibiotic Product Offerings
    Table 101. Meiji Holdings Recent Development
    Table 102. GSK Company Information
    Table 103. GSK Introduction and Business Overview
    Table 104. GSK Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. GSK Amoxicillin Antibiotic Product Offerings
    Table 106. GSK Recent Development
    Table 107. Novartis Company Information
    Table 108. Novartis Introduction and Business Overview
    Table 109. Novartis Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Novartis Amoxicillin Antibiotic Product Offerings
    Table 111. Novartis Recent Development
    Table 112. Centrient Pharma Company Information
    Table 113. Centrient Pharma Introduction and Business Overview
    Table 114. Centrient Pharma Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Centrient Pharma Amoxicillin Antibiotic Product Offerings
    Table 116. Centrient Pharma Recent Development
    Table 117. Teva Company Information
    Table 118. Teva Introduction and Business Overview
    Table 119. Teva Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Teva Amoxicillin Antibiotic Product Offerings
    Table 121. Teva Recent Development
    Table 122. Mylan Company Information
    Table 123. Mylan Introduction and Business Overview
    Table 124. Mylan Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Mylan Amoxicillin Antibiotic Product Offerings
    Table 126. Mylan Recent Development
    Table 127. Cipla Company Information
    Table 128. Cipla Introduction and Business Overview
    Table 129. Cipla Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Cipla Amoxicillin Antibiotic Product Offerings
    Table 131. Cipla Recent Development
    Table 132. NCPC Company Information
    Table 133. NCPC Introduction and Business Overview
    Table 134. NCPC Amoxicillin Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. NCPC Amoxicillin Antibiotic Product Offerings
    Table 136. NCPC Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Amoxicillin Antibiotic Downstream Customers
    Table 140. Amoxicillin Antibiotic Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Amoxicillin Antibiotic Product Picture
    Figure 2. Global Amoxicillin Antibiotic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Amoxicillin Antibiotic Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Amoxicillin Antibiotic Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Amoxicillin Antibiotic Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Amoxicillin Antibiotic Report Years Considered
    Figure 7. Global Amoxicillin Antibiotic Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Amoxicillin Antibiotic Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Amoxicillin Antibiotic Revenue in 2023
    Figure 10. Amoxicillin Antibiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Pill Picture
    Figure 12. Capsule Picture
    Figure 13. Powder Picture
    Figure 14. Global Amoxicillin Antibiotic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Amoxicillin Antibiotic Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Amoxicillin Antibiotic Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Amoxicillin Antibiotic Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Amoxicillin Antibiotic Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital Pharmacy
    Figure 20. Product Picture of Retail Pharmacy
    Figure 21. Product Picture of Online Pharmacy
    Figure 22. Global Amoxicillin Antibiotic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Amoxicillin Antibiotic Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Amoxicillin Antibiotic Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Amoxicillin Antibiotic Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Amoxicillin Antibiotic Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Amoxicillin Antibiotic Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Amoxicillin Antibiotic Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Amoxicillin Antibiotic Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Amoxicillin Antibiotic Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Amoxicillin Antibiotic Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Amoxicillin Antibiotic Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Amoxicillin Antibiotic Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Amoxicillin Antibiotic Sales Volume (%), (2019-2030)
    Figure 39. United States Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Amoxicillin Antibiotic Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Amoxicillin Antibiotic Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Amoxicillin Antibiotic Sales Value by Application (%), 2023 VS 2030
    Figure 60. Amoxicillin Antibiotic Industrial Chain
    Figure 61. Amoxicillin Antibiotic Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Central Nervous System (CNS) Stimulant Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-21X3644
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Subcutaneous Injection Immunoglobulin Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-18J1073
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Cold Treatment Drug Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22L5796
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Phosphodiesterase (PDE) inhibitors Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-3P4044
Fri Dec 27 00:00:00 UTC 2024

Add to Cart